3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 withdrawn. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Nevus: new trials by email Literature Review of Nevus trials Research Report on Nevus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetic Risk Stratification of Pediatric Skin Lesions DermTech PLA noninvasive adhesive biopsy - Skin Lesion, Nevus | Phase 1 | Enrolling by invitation | Massachusetts General Hospital | 100 | 2022-08-01 | 2026-05-22 |
| Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) 6MHP, NeoAg-mBRAF, PolyICLC - Melanoma, Ocular Melanoma | Phase 1 / Phase 2 | Completed | Craig L Slingluff, Jr | 22 | 2020-09-28 | 2024-07-16 |
| Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease Biospecimen Collection, Computed Tomography, Lumbar Puncture - Acral Lentiginous Melanoma, Central Nervous System Melanoma | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 75 | 2018-05-02 | 2026-08-19 |
| The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure Fat grafting - Scar, Nevus | Phase 1 / Phase 2 | Completed | Shanghai Jiao Tong University School of Medicine | 80 | 2011-01-01 | 2016-06-22 |
| Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia) 20% betulinic acid ointment, BA - Dysplastic Nevus Syndrome | Phase 1 / Phase 2 | Withdrawn | University of Illinois at Chicago | 2006-01-01 | 2021-06-28 | |
| Optical Clearing of the Skin in Conjunction With Laser Treatments Optical Clearing - Port Wine Stain, Nevus of Ota | Phase 1 | Completed | University of California, Irvine | 35 | 2004-03-01 | 2022-10-20 |
Cicatrix (2) · Melanoma (2) · Uveal Melanoma (2) · Acne Vulgaris (1) · Carcinoma, Non-Small-Cell Lung (1) · Dysplastic Nevus Syndrome (1) · Hypertrichosis (1) · Lung Neoplasms (1) · Meningeal Neoplasms (1) · Nevus of Ota (1) · Port-Wine Stain (1) · Sebaceous Gland Diseases (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Nevi and Melanomas (6) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (2) · Eye Neoplasms (2) · Fibrosis (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2)
Betulinic Acid (1) · Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · Specimen Handling (1) · Spinal Puncture (1)
Craig L Slingluff, Jr (1) · M.D. Anderson Cancer Center (1) · Massachusetts General Hospital (1) · Shanghai Jiao Tong University School of Medicine (1) · University of California, Irvine (1) · University of Illinois at Chicago (1)
United States (5) · China (1)
Craig L. Slingluff, Jr., MD (1) · Elena B Hawryluk, MD, PhD (1) · Isabella C Glitza, MD (1) · Kristen M Kelly, M.D (1) · Tapas K. Das Gupta, MD, PhD, DSc (1)